ARMP Armata Pharmaceuticals, Inc.
NYSE · SEC CIK 921114 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 56 since 2021-08-03, latest 2026-07-14 16:18
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kyme Pierre | Chief Business Off | — | — |
| Birx Deborah | CEO, Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 16:18 | 2026-07-10 | ARMP | Birx Deborah | CEO, Dir | F - Tax | $4.26 | -14.0K | 198.4K | -7% | -$59.8K | |
| 2026-03-17 | 2026-03-14 | ARMP | Kyme Pierre | Chief Business Off | F - Tax | $10.54 | -1,030 | 9,461 | -10% | -$10.9K | |
| 2026-03-17 | 2026-03-14 | ARMP | Birx Deborah | CEO, Dir | F - Tax | $10.54 | -4,919 | 212.5K | -2% | -$51.8K | |
| 2025-07-14 | 2025-07-10 | ARMP | Birx Deborah | CEO, Dir | F - Tax | $2.27 | -13.6K | 217.4K | -6% | -$31.0K | |
| 2025-04-25 | 2025-03-14 | ARMP | Kyme Pierre | Chief Business Off | F - Tax | $1.95 | -1,027 | 10.5K | -9% | -$2,003 | |
| M | 2025-04-25 | 2024-07-10+ | ARMP | Birx Deborah | CEO, Dir | F - Tax | $2.53 | -29.0K | 231.0K | -11% | -$73.3K |
| D | 2024-03-18 | 2024-03-14 | ARMP | Birx Deborah | CEO, Dir | A - Grant | $0.00 | +60.0K | 260.0K | +30% | $0 |
| D | 2024-03-18 | 2024-03-14 | ARMP | Rychlik Richard | Corp. Ctrl, PFO | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
| D | 2023-12-26 | 2023-12-21 | ARMP | Birx Deborah | CEO, Dir | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
| DI | 2022-04-01 | 2022-03-31 | ARMP | Innoviva, Inc. | Dir, 10% | P - Purchase | $5.00 | +5.39M | 16.37M | +49% | +$26.93M |
| DI | 2022-02-11 | 2022-02-09 | ARMP | Innoviva Strategic Opportunities LLC | Dir, 10% | P - Purchase | $5.00 | +3.61M | 10.98M | +49% | +$18.07M |
| I | 2021-11-01 | 2021-10-29 | ARMP | Innoviva Strategic Opportunities LLC | Dir, 10% | P - Purchase | $3.30 | +1.21M | 7.37M | +20% | +$4.00M |
Purchase Sale Sale after option exercise All abbreviations